Abstract
Metastatic Lymph Node 51 (MLN51) cDNA was isolated by differential screening of a human breast cancer metastasis cDNA library. MLN51 cDNA encodes a novel human protein of 703 residues that shares no significant homology to any known protein. However MLN51 is well conserved between vertebrate and invertebrate species suggesting an important biological function. The amino terminal half of the protein contains a coiled-coil domain and two potential nuclear localization signals (NLS). The carboxy terminal half contains one SH2 and four SH3 binding motifs. The coiled-coil domain promotes MLN51 oligomerization in transfected cells. When transiently expressed, the MLN51 protein is mainly found in the cytoplasm with a weak nuclear staining. However, deletion of the carboxy terminal half of the protein allows the targeting of the protein to the nucleus, demonstrating that the NLSs are functional. MLN51 is ubiquitously expressed in normal tissues. Human breast carcinomas show MLN51 overexpression in malignant epithelial cells. The uncommon association of protein–protein interaction domains often found either in nuclear or in cytoplasmic signaling proteins raises a possible nucleo-cytoplasmic function for MLN51.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ . 1997 Nucleic Acids Res. 25: 3389–3402
Bairoch A, Bucher P, Hofmann K . 1996 Nucleic Acids Res. 24: 189–196
Bieche I, Tomasetto C, Regnier CH, Moog-Lutz C, Rio MC, Lidereau R . 1996 Cancer Res. 56: 3886–3890
Boyle P, Maisonneuve P, Autier P . 2000 Int. J. Gynaecol. Obstet. 70: 263–303
Burkhard P, Stetefeld J, Strelkov SV . 2001 Trends Cell Biol. 11: 82–88
Chen C, Okayama H . 1987 Mol. Cell Biol. 7: 2745–2752
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ . 1979 Biochemistry 18: 5294–5299
Chomczynski P, Sacchi N . 1987 Anal. Biochem. 162: 156–159
Cohen GB, Ren R, Baltimore D . 1995 Cell 80: 237–248
Daigle I, Li C . 1993 Proc. Natl. Acad. Sci. USA 90: 12045–12059
Daly RJ . 1998 Cell Signal 10: 613–618
Dyrks T, Weidemann A, Multhaup G, Salbaum JM, Lemaire HG, Kang J, Muller-Hill B, Masters CL, Beyreuther K . 1988 EMBO J. 7: 949–957
Feinberg AP, Vogelstein B . 1983 Anal. Biochem. 132: 6–13
Hansen S, Lane DP, Midgley CA . 1998 J. Mol. Biol. 275: 575–588
Hobert O, Jallal B, Schlessinger J, Ullrich A . 1994 J. Biol. Chem. 269: 20225–20228
Holt MR, Koffer A . 2001 Trends Cell Biol. 11: 38–46
Jans DA, Xiao CY, Lam MH . 2000 Bioessays 22: 532–544
Kay BK, Williamson MP, Sudol M . 2000 FASEB J. 14: 231–241
Klapper LN, Kirschbaum MH, Sela M, Yarden Y . 2000 Adv. Cancer Res. 77: 25–79
Kozak M . 1987 J. Mol. Biol. 196: 947–950
Lehrach H, Diamond D, Wozney JM, Boedtker H . 1977 Biochemistry 16: 4743–4751
Liotta LA . 2001 Nature 410: 24–25
Lupas A . 1996 Methods Enzymol. 266: 513–525
Lupas A, Van Dyke M, Stock J . 1991 Science 252: 1162–1164
Mayer BJ . 2001 J. Cell Sci. 114: 1253–1263
Mayer BJ, Hamaguchi M, Hanafusa H . 1988 Nature 332: 272–275
Moog-Lutz C, Tomasetto C, Regnier CH, Wendling C, Lutz Y, Muller D, Chenard MP, Bassett P, Rio MC . 1997 Int. J. Cancer 71: 183–191
Nakai K, Horton P . 1999 Trends Biochem. Sci. 24: 34–36
O'Shea EK, Rutkowski R, Kim PS . 1992 Cell 68: 699–708
Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M . 1997 Cell 90: 373–383
Regnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Bassett P, Rio MC . 1995 J. Biol. Chem. 270: 25715–25721
Sadowski I, Stone JC, Pawson T . 1986 Mol. Cell Biol. 6: 4396–4408
Schlessinger J . 1994 Curr. Opin. Genet. Dev. 4: 25–30
Schreiber V, Moog-Lutz C, Regnier CH, Chenard MP, Boeuf H, Vonesch JL, Tomasetto C, Rio MC . 1998 Mol. Med. 4: 675–687
Shoeman RL, Traub P . 1993 Bioessays 15: 605–611
Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Farjardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC . 1993 Cell 72: 767–778
Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow JJ, Buchberg AM, Osborne CK, Margolis B . 1994 EMBO J. 13: 1331–1340
Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, Sugimachi K . 1997 Cancer Res. 57: 28–31
Taylor SJ, Shalloway D . 1994 Nature 368: 867–871
Tomasetto C, Moog-Lutz C, Regnier CH, Schreiber V, Basset P, Rio MC . 1995a FEBS Lett. 373: 245–249
Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC . 1995b Genomics 28: 367–376
Wahle E, Keller W . 1992 Ann. Rev. Biochem. 61: 419–440
Yan YT, Stein SM, Ding J, Shen MM, Abate-Shen C . 2000 Mol. Cell. Biol. 20: 661–671
Yu D, Hung MC . 2000 Oncogene 19: 6115–6121
Acknowledgements
The authors thank S Chan for critical reading of the manuscript; G Duval, P Eberling, I Stoll, M Gintz for technical assistance; F Alpy, for helpful discussions. This work was supported by funds from the Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Hôpital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, the Ligue Nationale Française contre le Cancer (LNCC), the LNCC Comités du Haut-Rhin et du Bas-Rhin and the Fondation de France. S Degot was a recipient of an Allocation du Ministère de l'Education Nationale, de la Recherche et de la Technologie.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Degot, S., Régnier, C., Wendling, C. et al. Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer. Oncogene 21, 4422–4434 (2002). https://doi.org/10.1038/sj.onc.1205611
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205611
Keywords
This article is cited by
-
Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis
Rheumatology International (2011)
-
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
Laboratory Investigation (2008)